▶ 調査レポート

局所麻酔薬の世界市場:局所麻酔薬別(ブピバカイン、ロピバカイン、リドカイン、クロロプロカイン、オキセタカイン、プリロカイン、ベンゾカイン、その他)、用途別(形成外科、美容整形外科、歯科、脊椎、末梢神経ブロック、硬膜外麻酔、斜角筋間ブロック、サドル(鞍状)ブロック、地域別分析

• 英文タイトル:Global Local Anesthesia Drugs Market - Segmented by Type of Anesthetics, and Application - Growth, Trends and Forecasts (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。局所麻酔薬の世界市場:局所麻酔薬別(ブピバカイン、ロピバカイン、リドカイン、クロロプロカイン、オキセタカイン、プリロカイン、ベンゾカイン、その他)、用途別(形成外科、美容整形外科、歯科、脊椎、末梢神経ブロック、硬膜外麻酔、斜角筋間ブロック、サドル(鞍状)ブロック、地域別分析 / Global Local Anesthesia Drugs Market - Segmented by Type of Anesthetics, and Application - Growth, Trends and Forecasts (2018 - 2023) / B-MOR-040918資料のイメージです。• レポートコード:B-MOR-040918
• 出版社/出版日:Mordor Intelligence / 2018年2月
• レポート形態:英文、PDF、113ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Single User(1名様用)¥484,500 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥513,000 (USD4,500)▷ お問い合わせ
  Corporate User¥997,500 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、局所麻酔薬の世界市場について調べ、局所麻酔薬の世界規模、市場動向、市場環境、局所麻酔薬別(ブピバカイン、ロピバカイン、リドカイン、クロロプロカイン、オキセタカイン、プリロカイン、ベンゾカイン、その他)分析、用途別(形成外科、美容整形外科、歯科、脊椎、末梢神経ブロック、硬膜外麻酔、斜角筋間ブロック、サドル(鞍状)ブロック分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・局所麻酔薬の世界市場インサイト
・局所麻酔薬の世界市場環境
・局所麻酔薬の世界市場動向
・局所麻酔薬の世界市場規模
・局所麻酔薬の世界市場規模:局所麻酔薬別(ブピバカイン、ロピバカイン、リドカイン、クロロプロカイン、オキセタカイン、プリロカイン、ベンゾカイン、その他)
・局所麻酔薬の世界市場規模:用途別(形成外科、美容整形外科、歯科、脊椎、末梢神経ブロック、硬膜外麻酔、斜角筋間ブロック、サドル(鞍状)ブロック
・局所麻酔薬の世界市場:地域別市場規模・分析
・局所麻酔薬の北米市場規模・予測
・局所麻酔薬のアメリカ市場規模・予測
・局所麻酔薬のヨーロッパ市場規模・予測
・局所麻酔薬のアジア市場規模・予測
・局所麻酔薬の日本市場規模・予測
・局所麻酔薬の中国市場規模・予測
・局所麻酔薬のインド市場規模・予測
・局所麻酔薬の韓国市場規模・予測
・関連企業情報・競争状況

The global local anesthesia drug market has been estimated to reach USD 6.02 billion in 2017.The global Local Anesthesia Drugs market is expected to register a CAGR of 3.9% during the forecast period, 2018 to 2023. North America dominates the market due to the growing demand of propofol.

Rising Number of Surgeries

According to the Center for Disease Control and Prevention (CDC), the total number of inpatient surgeries performed in the United States grew to 51.4 million, with the cardiology, surgical, and obstetrical procedures being the most common ones. In Europe, a greater number of surgeries are being performed for cases of cataract, tonsillectomy, colonoscopy, caesarean sections, and hip replacements. In addition, a number of procedures, such as cochlear implantation, laparoscopic colectomy, laparoscopic hysterectomy, secondary hip replacement, and knee replacement, have become more frequent in the recent years. NHS UK reports that there were around 4.7 million surgical admissions in 2013-14 in the United Kingdom, and during 2003-2014, the number of surgical procedures rose by 27%. The most common surgical procedures in the United Kingdom are hernia repairs, hip replacement, knee replacement, gall bladder removal, and tonsillectomies.
Additionally, NEW APPROVALS OF ANESTHETIC DRUGS AND INCREASE IN NUMBER OF COSMETICS SURGERIES ARE FUELLING THE GLOBAL LOCAL ANESTHESIA DRUGS MARKET.

Risk of Side Effects of Anesthetic Drugs

General anesthetic drugs causes several side-effects, including nausea, vomiting, dry mouth, sore throat, shivering, muscle aches, disorientation, itching, sleepiness, and mild hoarseness. Serious complications of the drug include delirium, cognitive dysfunction, and malignant hyperthermia. General anesthetic drugs can cause physiological changes, like blood pressure variations, and due to this, a trained anesthesiologist is expected to continuously monitor the patient’s blood pressure levels, providing blood pressure medications whenever necessary. Carelessness or lack of knowledge of the anesthesiologist could pose potential risks. Hence, the side-effects of general anesthesia and patient’s reluctance toward using it, are the factors that are restraining the segment’s growth.
Also, REGULATORY ISSUES BY THE GOVERNMENT are also restraining the Global Local Anesthesia Drug market.

North America to Dominate the Market

The Global local anesthesia drug market is segmented into type of anesthetics (general and local anesthetics), by application, by route o administration and by geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the global local anesthesia drugs market due to the increased demand of propofol, increasing focus of large number of vendors towards exploring new routes of administration such as oral and topical will also drive the preference in the anesthetic drugs market.

Key Developments in the Market

• August 2017: Akovaz (Ephedrine Sulfate) injection manufactured by Sandoz Inc. for the treatment of clinically important hypotension got approval of FDA.
• July 2017: Septocaine a local, infiltrative or conductive anesthesia which is used dental procedures developed by Hansamed Inc. got FDA approval.

Key players: BAXTER, MYLAN, ABBOTT, ASTRAZENECA, TEVA PHARMACEUTICALS, PFIZER, FRESENIUS SE & CO, and HIKMA PHARMACEUTICALS PLC.

REASONS TO PURCHASE THIS REPORT

• Market analysis for the Global Local Anesthesia Drugs Market, with region-specific assessments and competition analysis on a global and regional scale.
• Analyzing various perspectives of the industry with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet in excel.

CUSTOMIZATION OF THE REPORT

• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

レポート目次

TABLE OF CONTENTS
1. INTRODUCTION
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTERS FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 RISING NUMBER OF SURGERIES
6.1.2 NEW APPROVALS OF ANESTHETIC DRUGS
6.1.3 INCREASE IN NUMBER OF COSMETICS SURGERIES
6.2 MARKET RESTRAINTS
6.2.1 RISK OF SIDE EFFECTS OF ANESTHETIC DRUGS
6.2.2 REGULATORY ISSUES BY THE GOVERNMENT
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
6.4.1 MARKET SEGMENTATION
6.4.1.1 SEGMENTATION BY LOCAL ANESTHETICS
6.4.1.2 BUPIVACAINE
6.4.1.3 ROPIVACAINE
6.4.1.4 LIDOCAINE
6.4.1.5 CHLOROPROCAINE
6.4.1.6 OXETHAZAINE
6.4.1.7 PRILOCAINE
6.4.1.8 BENZOCAINE
6.4.2 OTHER LOCAL ANESTHETICS
6.4.2.1 SEGMENTATION BY APPLICATION
6.4.2.2 PLASTIC SURGERY
6.4.2.3 COSMETICS
6.4.2.4 DENTAL ANESTHETICS
6.4.2.5 SPINAL ANESTHETICS
6.4.2.6 PERIPHERAL NERVE BLOCK
6.4.2.7 EPIDURAL
6.4.2.8 INTERSCALENE BLOCK
6.4.2.9 SADDLE BLOCK
7. OTHERS
7.1 SEGEMENTATION BY GEOGRAPHY
7.1.1 NORTH AMERICA
7.1.1.1 UNITED STATES
7.1.1.2 CANADA
7.1.1.3 MEXICO
7.1.2 EUROPE
7.1.2.1 FRANCE
7.1.2.2 GERMANY
7.1.2.3 UNITED KINGDOM
7.1.2.4 ITALY
7.1.2.5 SPAIN
7.1.2.6 REST OF EUROPE
7.1.3 ASIA-PACIFIC
7.1.3.1 CHINA
7.1.3.2 JAPAN
7.1.3.3 INDIA
7.1.3.4 AUSTRALIA & NEW ZEALAND
7.1.3.5 SOUTH KOREA
7.1.3.6 REST OF ASIA-PACIFIC
7.1.4 MIDDLE EAST AND AFRICA
7.1.4.1 GCC
7.1.4.2 SOUTH AFRICA
7.1.4.3 REST OF MIDDLE EAST AND AFRICA
7.1.5 SOUTH AMERICA
7.1.5.1 BRAZIL
7.1.5.2 ARGENTINA
7.1.5.3 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITION ANALYSIS
8.2 AGREEMENTS, COLLABORATIONS & PARTNERSHIPS
8.3 NEW PRODUCTS LAUNCHES
9. COMPANY PROFILES
9.1 BAXTER
9.2 MYLAN
9.3 ABBOTT
9.4 ASTRAZENECA
9.5 TEVA PHARMACEUTICALS
9.6 PFIZER
9.7FRESENIUS SE & CO
9.8 HIKMA PHARMACEUTICALS PLC
10. FUTURE OUTLOOK OF THE MARKET